Eris Lifesciences Limited — Updates, 26-08-2025: Press Release
26-08-2025 | 11:50 am
26-08-2025 | 11:50 am
Eris Lifesciences' subsidiary secured ANVISA approval for its sterile injectable facility, enabling product launches in Brazil. This expands Latin American market coverage, reinforcing its strategic focus on complex injectables and biotechnology.
No comments yet. Be the first to comment!
